BoyleP,NapalkovP., 1995.The epidemiology of benign prostatic hyperplasia and observations on concomitant hypertension,Scand J Urol Nephrol Suppl 168 7 -12
SmithAB,CarsonCC, 2009.Fanasteride in the treatment of patients with benign prostatic hyperplasia: a review,Ther Clin Risk Manag 5 535 -45
HochbergDA,BasilloteJB,ArmenakasNA,VasovicL,ShevchukM,PareekG, 2002.Decreased suburothelial prostatic microvessel density in finasteride treated prostate: a possible mechanism for reduced bleeding in benign prostatic hyperplasia,J Urol 167 1731 -3
FoleySJ,SolomanLZ,WedderburnAW, 2000.A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride,J Urol 163 496 -8
OzdalOL,OzdenC,BenliK,GokkayaS,BulutS,MemisA, 2005.Effect of short term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of prostate: a randomized controlled study,Prostate Cancer Prostatic Dis 8 215 -8
ZongHT,PengXX,YangCC,ZhangY., 2011.A systematic review of the effects and mechanisms of preoperative 5α-reductase inhibitors on intraoperative haemorrhage during surgery for benign prostatic hyperplasia,Asian J Androl 13 812 -8
MemisA,OzdenC,OzdalOL,GuzelO,HanO,SeckinS, 2008.Effect of finasteride treatment on suburethral prostatic microvessel density in patients with hematuria related to benign prostate hyperplasia,Urol Int 80 177 -80
DonohueJF,Hayned,ThomasDR,FosterMC, 2005.Randomized, placebo controlled trial showing that finasteride reduces prostate vascularity rapidly within 2 weeks,BJU Int 96 1319 -22
De BerardinisE,AntoniniG,BusettoGM,GentileV,Di SilverioF,RossiA, 2008.Reduced intraoperative bleeding during transurethral resection of the prostate: evaluation of finasteride, vascular endothelial growth factor, and CD34,Current Prostate Reports 6 123 -7
McVaryKT,RoehrbornCG,AvinsAL, 2011.Update on AUA guideline on the management of benign prostatic hyperplasia,J Urol 185 1793 -1803
McVaryKT,RoehrbornCG,AvinsAL,BarryMJ,BruskewitzRC,DonnellRF, 2010.American Urological Association Guidelines: management of benign prostatic hyperplasia BPH),American Urological Association -
ZaitsuM,TonookaA,MikamiK,HattoriM,TakeshimaY,UekusaT, 2013.A Dual 5α-Reductase inhibitor dutasteride caused reductions in vascular density and area in benign prostatic hyperplasia,ISRN Urol 863489 -
RassweilerJ,TeberD,KuntzR,HofmanR, 2006.Complication of transurethral resection of prostate - incidence, management and prevention,Eur Urol 50 969 -80
AboumarzoukOM,AslamMZ,WedderburnA,TurnerK,HughesO,KynastonHG, 2013.Should finasteride be routinely given preoperatively for TURP? ISRN Urol, 458353 -
KavanaghLE,JackGS,LawrentschukN, 2011.Prevention and management of TURP-related hemorrhage,Nat Rev Urol 8 504 -14
JiangY,Long YF, 2010.Effects of finasteride on hematuria associated with benign prostatic hyperplasia: a meta-analysis,Zhonghua Nan KeXue 16 726 -9
VasdevN,KumarA,VeeratterapillayR,ThorpeAC, 2013.Hematuria secondary to benign prostatic hyperplasia: retrospective analysis of 166 men identified in a single one stop hematuria clinic,Curr Urol 6 146 -9
NikhilVasdev, 2013.Hematuria secondary to benign prostatic hyperplasia: retrospective analysis of 166 men identified in a single one stop hematuria,Clinic Curr Urol 6 146 -9
PastoreAL,MarianiS,BarreseF,PalleschiG,ValentiniAM,PaciniL, 2013.Transurethral resection of prostate and the role of pharmacological treatment with dutasteride in decreasing surgical blood loss,J Endourol 27 68 -70
SugieS,MukaiS,TsukinoH,IwamotoH,KobayashiT,TodaY, 2014.Effect of dutasteride on microvessel density in benign prostatic hyperplasia,In Vivo 28 355 -9
HyunJH,ChoKH,HanDS,KimJB,ChangYS, 2009.The effect of finasteride on microvessel density and expression of vascular endothelial growth factor and 5 α-reductase in prostatic hyperplasia,Korean J Urol 50 947 -54
LiuXD,YangYR,LuYP,ZhangXH,LiFY, 2003.Preoperative finasteride on decreasing operative bleeding during transurethral resection of prostate,Chin J Urol 24 694 -6
PareekG,ShevchukM,ArmenakasNA, 2003.The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mechanism for decreased prostatic bleeding in treated patients,J Urol 169 20 -3
HaggstromS,TørringN,MøllerK,JensenE,Lund L, 2002.Effects of finasteride on vascular endothelial growth factor - a placebo controlled randomized study in BPH patients,Scand J Urol Nephrol 36 182 -7